Repurposing of Existing Antibiotics for the Treatment of Diabetes Mellitus

Overview

Journal In Silico Pharmacol

Date 2022 Mar 11

PMID 35273901

Authors

Muhammad Shaiful Alam

Md Sohorab Uddin

Tahmida Shamsuddin

Maruf Rubayed

Tania Sharmin

Rasheda Akter

S M Zahid Hosen

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-021-00118-6.

References

Honarparvar B, Govender T, Maguire G, Soliman M, Kruger H . Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity. Chem Rev. 2013; 114(1):493-537. DOI: 10.1021/cr300314q. View

Fujiwara K, Inoue T, Yorifuji N, Iguchi M, Sakanaka T, Narabayashi K . Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration. J Clin Biochem Nutr. 2015; 56(2):155-62. PMC: 4345177. DOI: 10.3164/jcbn.14-111. View

Chen F, Liu H, Sun H, Pan P, Li Y, Li D . Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking. Phys Chem Chem Phys. 2016; 18(32):22129-39. DOI: 10.1039/c6cp03670h. View

Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View

Li J, Abel R, Zhu K, Cao Y, Zhao S, Friesner R . The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins. 2011; 79(10):2794-812. PMC: 3206729. DOI: 10.1002/prot.23106. View

Dickson C, Madej B, Skjevik A, Betz R, Teigen K, Gould I . Lipid14: The Amber Lipid Force Field. J Chem Theory Comput. 2014; 10(2):865-879. PMC: 3985482. DOI: 10.1021/ct4010307. View

Pospisilik J, Stafford S, Demuth H, Brownsey R, Parkhouse W, Finegood D . Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes. 2002; 51(4):943-50. DOI: 10.2337/diabetes.51.4.943. View

Enk J, Mandelboim O . The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes. Front Immunol. 2014; 5:4. PMC: 3895823. DOI: 10.3389/fimmu.2014.00004. View

Duckworth C, Fisher J, Carter S, Newman C, Cogburn C, NESBIT R . Tissue penetration of clindamycin in diabetic foot infections. J Antimicrob Chemother. 1993; 31(4):581-4. DOI: 10.1093/jac/31.4.581. View

10.

Meng W, Brigance R, Chao H, Fura A, Harrity T, Marcinkeviciene J . Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors. J Med Chem. 2010; 53(15):5620-8. DOI: 10.1021/jm100634a. View

11.

Sun H, Li Y, Shen M, Tian S, Xu L, Pan P . Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. Phys Chem Chem Phys. 2014; 16(40):22035-45. DOI: 10.1039/c4cp03179b. View

12.

Shah P, Mudaliar S . Pioglitazone: side effect and safety profile. Expert Opin Drug Saf. 2010; 9(2):347-54. DOI: 10.1517/14740331003623218. View

13.

Kam J, Puranik S, Yadav R, Manwaring H, Pierre S, Srivastava R . Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help. Front Plant Sci. 2016; 7:1454. PMC: 5037128. DOI: 10.3389/fpls.2016.01454. View

14.

Shelley J, Cholleti A, Frye L, Greenwood J, Timlin M, Uchimaya M . Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des. 2007; 21(12):681-91. DOI: 10.1007/s10822-007-9133-z. View

15.

Krieger E, Vriend G . New ways to boost molecular dynamics simulations. J Comput Chem. 2015; 36(13):996-1007. PMC: 6680170. DOI: 10.1002/jcc.23899. View

16.

Xu L, Sun H, Li Y, Wang J, Hou T . Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. J Phys Chem B. 2013; 117(28):8408-21. DOI: 10.1021/jp404160y. View

17.

Bae E . DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control. Arch Pharm Res. 2016; 39(8):1114-28. DOI: 10.1007/s12272-016-0813-x. View

18.

Linn T, Schneider K, Goke B, Federlin K . Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice. Acta Diabetol. 1996; 33(1):19-24. DOI: 10.1007/BF00571935. View

19.

Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

20.

Pickup J, Crook M . Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia. 1998; 41(10):1241-8. DOI: 10.1007/s001250051058. View